Cataract Ocular disease
Conditions
Interventions
Implantation of Clareon PanOptix multifocal intraocular lenses in both eyes during surgery of bilateral cataract patients.
Sponsors
Bissen Hiroko
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who meet all of the following criteria are included in this study: 1) Patients who will undergo bilateral cataract surgery and are eligible for multifocal IOL implantation in both eyes. 2) Patients aged from 40 to 79 years when enrolled. 3) Patients whose preoperative corneal astigmatism of 1.0 D or less. 4) Patients whose postoperative corrected distance visual acuity is expected to be 0.5 or better.
Exclusion criteria
Exclusion criteria: 1) Patients with any ocular disease influencing visual function, except for cataract. 2) Patients with irregular corneal astigmatism. 3) Patients with history of intraocular or corneal surgery 4) Patients with other systemic or ophthalmic diseases considered to be unsuitable by an investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Binocular distance-corrected visual acuities at distances of 40 cm, 60 cm, and 5 m at 3 months after bilateral implantation of intraocular lenses. | — |
Secondary
| Measure | Time frame |
|---|---|
| At 3 months after bilateral implantation of intraocular lenses: 1) Uncorrected and distance-corrected visual acuities at distances of 40 cm, 60 cm, 80 cm, and 5 m (monocular and binocular) 2) Binocular defocus curve 3) Binocular photopic contrast sensitivity 4) Preoperative and postoperative QOL questionnaire 5) Equivalence to previously reported data on the same type of intraocular lens made of AcrySof material in the above items Others; Postoperative subjective symptoms and its frequency and severity. Occurrences of adverse events and product deficiencies. | — |
Contacts
Public ContactHiroko Bissen
Tokyo Dental Collage Suidobashi Hospital
Outcome results
None listed